These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8397948)

  • 1. HIV testing and unreported HIV positivity among injecting drug users in London.
    Donoghoe MC; Rhodes TJ; Hunter GM; Stimson GV
    AIDS; 1993 Aug; 7(8):1105-11. PubMed ID: 8397948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevalence no higher among female drug injectors also involved in prostitution.
    Rhodes T; Donoghoe M; Hunter G; Stimson GV
    AIDS Care; 1994; 6(3):269-76. PubMed ID: 7948083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow.
    Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A
    AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV prevalence and risk behaviour among female injecting drug users in London, 1990 to 1996.
    Judd A; Hunter GM; Maconochie N; Hickman M; Parry JV; Renton AM; Stimson GV
    AIDS; 1999 May; 13(7):833-7. PubMed ID: 10357383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
    Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 prevalence in community-wide samples of injecting drug users in London, 1990-1993.
    Stimson GV; Hunter GM; Donoghoe MC; Rhodes T; Parry JV; Chalmers CP
    AIDS; 1996 Jun; 10(6):657-66. PubMed ID: 8780821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual behaviour of drug injectors in London: implications for HIV transmission and HIV prevention.
    Rhodes T; Donoghoe M; Hunter G; Soteri A; Stimson GV
    Addiction; 1994 Sep; 89(9):1085-96. PubMed ID: 7987185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimates of HIV infection among injecting drug users in Glasgow, 1985-1990.
    Frischer M; Green ST; Goldberg DJ; Haw S; Bloor M; McKeganey N; Covell R; Taylor A; Gruer LD; Kennedy D
    AIDS; 1992 Nov; 6(11):1371-5. PubMed ID: 1472341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group.
    Health Bull (Edinb); 1993 Nov; 51(6):418-29. PubMed ID: 8307755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
    Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued risk behaviour among HIV positive drug injectors in London: implications for intervention.
    Rhodes TJ; Donoghoe MC; Hunter GM; Stimson GV
    Addiction; 1993 Nov; 88(11):1553-60. PubMed ID: 8287001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence.
    Platt L; Rhodes T; Hickman M; Mikhailova L; Lisetsky K; Sarang A; Lewis K; Parry J
    J Acquir Immune Defic Syndr; 2008 Apr; 47(5):623-31. PubMed ID: 18209680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anonymous HIV surveillance in Saughton Prison, Edinburgh.
    Bird AG; Gore SM; Jolliffe DW; Burns SM
    AIDS; 1992 Jul; 6(7):725-33. PubMed ID: 1503691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
    van Beek I; Chronister KJ
    Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low and stable prevalence of HIV among drug injectors in Glasgow.
    Taylor A; Frischer M; Green ST; Goldberg D; McKeganey N; Gruer L
    Int J STD AIDS; 1994; 5(2):105-7. PubMed ID: 8031910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.